Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
TOPAMAX
Generic name / active ingredient
topiramate tablets / sprinkle capsules
Dosage-form class
TOPAMAX topiramate coated oral tablets (25, 50, 100 and 200 mg per tablet) and sprinkle capsules (15 and 25 mg per capsule). Conventional tablets must be swallowed whole and not chewed. Sprinkle capsules may be swallowed whole or opened so all contents are placed on one teaspoon of soft food and swallowed immediately; do not chew or store the mixture.
Route
Oral
Record reviewed
2026-09-04

Copy from the pack in hand

Source-linked reading points

  • New reduced vision, visual disturbance or eye pain may signal an urgent eye problem. The label warns that untreated secondary angle-closure glaucoma can cause permanent visual loss. Do not wait for a website judgment or choose a stopping speed yourself; seek prompt professional care.
  • Topiramate can lower serum bicarbonate and cause metabolic acidosis. Kidney disease, severe respiratory disorders, diarrhoea, a ketogenic diet or other acidosis-producing medicines can add risk. The label recommends baseline and periodic bicarbonate measurement; the site cannot replace tests or adjust a dose from them.
  • Changes in thinking, attention, memory, speech, reaction speed, sleepiness, dizziness or coordination may affect driving and increase fall risk in older adults. Have the actual changes, fall history, kidney function, complete medicine list and exact pack reviewed together.
  • Concomitant valproate (such as DEPAKOTE) is associated with hyperammonaemia/encephalopathy and hypothermia. Other carbonic-anhydrase inhibitors, acidosis-producing medicines or a ketogenic diet also require kidney-stone risk review. Self-separating times does not solve these issues, and a shared antiseizure use or milligram figure does not permit one-for-one switching.

Reviewed presentation examples — compare every field

  • Topiramate 25 mg per tablet; 60-tablet bottle with desiccantNDC 50458-639-65
  • Topiramate 50 mg per tablet; 60-tablet bottle with desiccantNDC 50458-640-65
  • Topiramate 100 mg per tablet; 60-tablet bottle with desiccantNDC 50458-641-65
  • Topiramate 200 mg per tablet; 60-tablet bottle with desiccantNDC 50458-642-65
  • Topiramate 15 mg per capsule; 60-capsule bottleNDC 50458-647-65
  • Topiramate 25 mg per capsule; 60-capsule bottleNDC 50458-645-65

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-04
Source record
4 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image